2018
DOI: 10.1007/s13304-018-0596-3
|View full text |Cite
|
Sign up to set email alerts
|

The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 31 publications
0
11
0
1
Order By: Relevance
“…The ALPPS registry did not reveal any morbidity or mortality rates after rescue ISLT [5]. However, our patient collective demonstrated an average age of 67 years; this might be relevant for the interpretation of the herein reported mortality because patient age beyond 60 years is associated with an increased risk for morbidity and mortality due to impaired regenerative potential [45].…”
Section: Discussionmentioning
confidence: 54%
“…The ALPPS registry did not reveal any morbidity or mortality rates after rescue ISLT [5]. However, our patient collective demonstrated an average age of 67 years; this might be relevant for the interpretation of the herein reported mortality because patient age beyond 60 years is associated with an increased risk for morbidity and mortality due to impaired regenerative potential [45].…”
Section: Discussionmentioning
confidence: 54%
“…The surgical indication for HCC with intrahepatic tumor thrombus is the most novel aspect of this case. The application of ALPPS for large HCC has been associated with variable results in the literature . The most important factor limiting the application of ALPPS in patients affected by HCC is the presence of fibrosis and cirrhosis that may limit regeneration, along with the increased risk of both interstage and overall morbidity.…”
Section: Discussionmentioning
confidence: 99%
“…The application of ALPPS for large HCC has been associated with variable results in the literature. [25][26][27][28] The most important factor limiting the application of ALPPS in patients affected by HCC is the presence of fibrosis and cirrhosis that may limit regeneration, along with the increased risk of both interstage and overall morbidity. In our case, despite the presence of chronic HBV infection, there were no signs of cirrhosis or reduced liver function, as indicated by normal blood tests, and no evidence of clinically significant portal hypertension.…”
Section: Discussionmentioning
confidence: 99%
“…55 The experiences from Hong Kong, Rome and Fudan show that in selected patients ALPPS seems to be an attractive approach to increase resectability in HCC patients otherwise left with palliative treatment options. [54][55][56]…”
Section: Phc 5%mentioning
confidence: 99%